Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
16.07
+0.04 (0.25%)
At close: Jul 14, 2025, 4:00 PM
16.97
+0.90 (5.60%)
After-hours: Jul 14, 2025, 7:34 PM EDT
Pulse Biosciences Market Cap
Pulse Biosciences has a market cap or net worth of $1.08 billion as of July 14, 2025. Its market cap has increased by 95.35% in one year.
Market Cap
1.08B
Enterprise Value
970.39M
1-Year Change
95.35%
Ranking
Category
Stock Price
$16.07
Market Cap Chart
Since May 18, 2016, Pulse Biosciences's market cap has increased from $52.40M to $1.08B, an increase of 1,963.15%. That is a compound annual growth rate of 39.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 11, 2025 | 1.08B | 0.69% |
Dec 31, 2024 | 1.07B | 59.11% |
Dec 29, 2023 | 673.10M | 552.86% |
Dec 30, 2022 | 103.10M | -76.50% |
Dec 31, 2021 | 438.80M | -27.42% |
Dec 31, 2020 | 604.60M | 116.86% |
Dec 31, 2019 | 278.80M | 43.19% |
Dec 31, 2018 | 194.70M | -49.52% |
Dec 29, 2017 | 385.70M | 345.90% |
Dec 30, 2016 | 86.50M | 65.08% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 717.60B |
Johnson & Johnson | 377.32B |
AbbVie | 338.30B |
Novo Nordisk | 308.09B |
UnitedHealth Group | 272.67B |
Novartis AG | 237.08B |
Abbott Laboratories | 229.71B |
AstraZeneca | 222.35B |